Drugs / Cellegesic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00522041 | Aug 2007 → Jul 2008 | ulcer of anus and rectum | Forest Laboratories | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellegesic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00522041 ↗ |
| Route | Other | “Participants applied Cellegesic 375 mg ointment containing approximately 1.5 mg of nitroglycerin anally twice daily for 21 days.” NCT00522041 ↗ |